Carnosine is a natural dipeptide able to react with reactive carbonyl species, which have been recently associated with the onset and progression of several human diseases. Herein, we report an intervention study in overweight individuals. Carnosine (2 g/day) was orally administered for twelve weeks in order to evaluate its bioavailability and metabolic fate. Two carnosine adducts were detected in the urine samples of all subjects. Such adducts are generated from a reaction with acrolein, which is one of the most toxic and reactive compounds among reactive carbonyl species. However, neither carnosine nor adducts have been detected in plasma. Urinary excretion of adducts and carnosine showed a positive correlation although a high variability of individual response to carnosine supplementation was observed. Interestingly, treated subjects showed a significant decrease in the percentage of excreted adducts in reduced form, accompanied by a significant increase of the urinary excretion of both carnosine and carnosine-acrolein adducts. Altogether, data suggest that acrolein is entrapped in vivo by carnosine although the response to its supplementation is possibly influenced by individual diversities in terms of carnosine dietary intake, metabolism and basal production of reactive carbonyl species.

A carnosine intervention study in overweight human volunteers: Bioavailability and reactive carbonyl species sequestering effect / L. Regazzoni, B. De Courten, D. Garzon, A. Altomare, C. Marinello, M. Jakubova, S. Vallova, P. Krumpolec, M. Carini, J. Ukropec, B. Ukropcova, G. Aldini. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 6(2016), pp. 27224.1-27224.13. [10.1038/srep27224]

A carnosine intervention study in overweight human volunteers: Bioavailability and reactive carbonyl species sequestering effect

L. Regazzoni
Primo
;
D. Garzon;A. Altomare;C. Marinello;M. Carini;G. Aldini
2016

Abstract

Carnosine is a natural dipeptide able to react with reactive carbonyl species, which have been recently associated with the onset and progression of several human diseases. Herein, we report an intervention study in overweight individuals. Carnosine (2 g/day) was orally administered for twelve weeks in order to evaluate its bioavailability and metabolic fate. Two carnosine adducts were detected in the urine samples of all subjects. Such adducts are generated from a reaction with acrolein, which is one of the most toxic and reactive compounds among reactive carbonyl species. However, neither carnosine nor adducts have been detected in plasma. Urinary excretion of adducts and carnosine showed a positive correlation although a high variability of individual response to carnosine supplementation was observed. Interestingly, treated subjects showed a significant decrease in the percentage of excreted adducts in reduced form, accompanied by a significant increase of the urinary excretion of both carnosine and carnosine-acrolein adducts. Altogether, data suggest that acrolein is entrapped in vivo by carnosine although the response to its supplementation is possibly influenced by individual diversities in terms of carnosine dietary intake, metabolism and basal production of reactive carbonyl species.
tandem mass-spectrometry; human serum-albumin; protein carbonylation; lipid-peroxidation; skeletal-muscle; renal-disease; adducts; detoxification; metabolism; products
Settore CHIM/08 - Chimica Farmaceutica
2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
carnosine_scientific_report_2016.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 990.78 kB
Formato Adobe PDF
990.78 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/430239
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 49
social impact